JDRF Presents South Florida Resident John Cammett with the 2022 John Brady Award for Innovation
Naples, FL and New York, November 3, 2022—JDRF, the leading global type 1 diabetes research and advocacy organization, proudly announces John Cammett as the recipient of the 2022 John Brady Award for Innovation in recognition of his longstanding leadership.
Established in 2019, the John Brady Award for Innovation recognizes an outstanding JDRF volunteer who has exhibited leadership in pioneering projects or ideas with the potential to meaningfully impact the type 1 diabetes (T1D) community. The Award is named after John Brady, a longtime JDRF volunteer whose son was diagnosed with T1D at the age of three in 1992. Mr. Brady was a member of the JDRF International Board of Directors for seven years and served as its chairman from 2014 to 2016.
Inspired by his late mother Barbara’s almost 60 years of living with T1D, Mr. Cammett is passionate about advancing life-changing research. He leads by example through his personal fundraising efforts and spurs others to action, which is exemplified in his role in helping establish the JDRF New England Center of Excellence, which provides a more efficient and closer collaboration between the powerhouse of JDRF and the New England research community. Mr. Cammett was diagnosed with T1D when he was 32 years-old, the same age of diagnosis as his beloved mother.
“John Cammett has led the way at the inception of some of our most bold and innovative research and development investments, helping to push forward transformative programs to accelerate the progression of research in the T1D space. His role in establishing the New England Center of Excellence is a prime example of his dedication,” said Aaron Kowalski, Ph.D., JDRF CEO. “It is with great pride and admiration that we present this award to John, a true T1D champion.”
In addition to his leadership with the Center, as a member of the JDRF Southern Florida chapter, Mr. Cammett is a consummate volunteer partner helping to enrich localized fundraising efforts, including the gala and golf tournament. Mr. Cammett currently serves as the host and co-chair of the Naples Fund a Cure Invitational Golf Event and as a mentor to local volunteers as well as a coach and counsel to others living with T1D. He has been a faithful JDRF volunteer for more than a decade and is a past national finance committee member.
Mr. Cammett, a lifelong entrepreneur who made his first deal at 23, boasts nearly 30 years of experience in all aspects of real estate, including finance, investment, management, and leasing. He is the co-founder of Realterm Global, a vertically integrated industrial real estate development and investment management company with a primary focus on transportation facilities serving the global supply chain. Mr. Cammett holds a bachelor’s degree in engineering and applied sciences from Harvard University.
“JDRF is a better organization because we have volunteers like John Cammett,” said John Brady. “His longstanding and selfless commitment to our mission begins in south Florida and emanates throughout the nation.”
JDRF recognizes and appreciates all of the dedicated volunteers and supporters who commit their lives to the worldwide effort to end T1D. Volunteer award recipients are recognized at the annual JDRF One Conference in Washington, D.C.
JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally and globally for efficiency and broader fundraising impact, and uniting on a global stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement, and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).
About Type 1 Diabetes (T1D)
T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all, leading to long-term complications which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves and heart; and even death if left untreated. It is one of the fastest-growing chronic health conditions. Many believe T1D is only diagnosed in childhood and early puberty, but diagnosis in adulthood is on the rise, and accounts for nearly 50% of all T1D diagnoses. The onset is sudden and nothing can be done to prevent it yet—it is not related to diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.